(2025). Neurofunctional Reversibility in Psoriasis Vulgaris After IL-17A Inhibition: A Resting-State fMRI and Neurocognitive Analysis. Psoriasis : Targets and Therapy.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Neurofunctional Reversibility in Psoriasis Vulgaris After IL-17A Inhibition: A Resting-State FMRI and Neurocognitive Analysis."
Psoriasis : Targets and Therapy 2025.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Neurofunctional Reversibility in Psoriasis Vulgaris After IL-17A Inhibition: A Resting-State FMRI and Neurocognitive Analysis."
Psoriasis : Targets and Therapy, 2025.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.